Before treatment with PLUVICTO
A PSMA PET scan will check for PSMA+ cancer in your body
A PSMA PET scan will check for PSMA+ cancer in your body
If you have already been treated with other anticancer treatments and your doctor determines that PLUVICTO is an appropriate treatment, he/she will refer you to a radiation oncologist or nuclear medicine treatment facility to receive PLUVICTO.
PLUVICTO is given once every 6 weeks for up to 6 treatments, depending on how your body responds
Be sure to follow instructions given by your health care provider.
PSMA+, prostate-specific membrane antigen positive.
What is the most important information I should know about PLUVICTO?
Use of PLUVICTO involves exposure to radioactivity. Long-term, accruing radiation exposure is associated with an increased risk for cancer...
What is PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan)?
PLUVICTO is a radiopharmaceutical used to treat adults with an advanced cancer called prostate-specific membrane antigen–positive metastatic castration-resistant prostate cancer (PSMA-positive mCRPC) that...